CeQur

CeQur

Private
Horw, LucerneHealthcare & Life Scienceshttps://www.myceqursimplicity.com

Last Round

Early Funding

1/7/2025

Total Funding Raised

$391.6M

Momentum Score

25 /100

Company Overview

CeQur Simplicity is a healthcare company that develops innovative drug delivery devices to simplify insulin administration and enhance the quality of life for diabetes patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

insulin patchpatch pumpwearable insulin deliverybolus insulin deliverymealtime insulininjection-free insulindiabetes technologytype 2 diabetesbolus-only patchdisposable medical deviceFDA-cleared devicepharmacy benefit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CeQur Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CeQur Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Funding1/7/2025
Series C Extension4/13/2021
Series C9/1/2015
Series B9/9/2013
Series A1/5/2010

Key People

Founding team and executive leadership

Bradley Paddock

President CEO

Executive Team

Michael Rubino

Chief Financial Officer

Executive Team

CeQur Investors

Notable investors and investment history

InvestorRounds
GMS CapitalSeries C Extension
VI PartnersSeries C Extension, Early Funding, Series C, Series A, Series B
Woodford Investment ManagementSeries C
Endeavour VisionEarly Funding, Series B, Series C, Series A, Series C Extension
Schroder & Co. BankSeries C Extension, Series B
Arthurian Life SciencesSeries C
Credit Suisse NEXT InvestorsSeries C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2025

    $120M raised in early funding.

CeQur Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CeQur Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CeQur's valuation, stock price, and market status.

Firmographic Details

HeadquartersHorw, Lucerne
Employee Range140
Year Founded2008
Last Funding1/7/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.